Medicinal Cannabis Products, Made in New Zealand
Cannasouth was New Zealand’s first medicinal cannabis company to list on the New Zealand Stock Exchange (NZX main board). We are a biopharmaceutical company dedicated to medicinal cannabis product development and research. Our goal is to develop New Zealand grown medicinal cannabis products for prescribers and patients and to export these high-quality products globally.
Our cannabis medication and medicinal cannabis products will be produced using cannabinoid extracts that come from high-quality, medical-grade cannabis cultivars. These medicines will be manufactured under GMP regulations using environmentally friendly methods, ensuring patients are treated with sophisticated medicines made of pure therapeutic compounds of the highest quality.
Cannasouth provides medicinal cannabis clinical data, educational material and media for specialists, doctors, and clinicians enabling informed patient treatment choices.
Supporting patient access to high-quality educational material regarding cannabinoid therapeutics is central to meaningful health outcomes.
Our investors are critical to the success of the company. We acknowledge the special trust they place in us with our commitment to the expansion of Cannasouth.